Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer

[1]  T. Nozoe,et al.  Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma , 2008, Surgery Today.

[2]  Wei-Chih Liao,et al.  Serum Interleukin-6 Level but not Genotype Predicts Survival after Resection in Stages II and III Gastric Carcinoma , 2008, Clinical Cancer Research.

[3]  S. Paterson-Brown,et al.  Clinical prognostic scoring system to aid decision‐making in gastro‐oesophageal cancer , 2007, The British journal of surgery.

[4]  P. Speiser,et al.  C-reactive protein is a prognostic parameter in patients with cervical cancer. , 2007, Gynecologic oncology.

[5]  Y. Jeng,et al.  IL‐6 induces AGS gastric cancer cell invasion via activation of the c‐Src/RhoA/ROCK signaling pathway , 2007, International journal of cancer.

[6]  J. Manson,et al.  C-reactive protein and risk of breast cancer. , 2007, Journal of the National Cancer Institute.

[7]  S. Bojesen,et al.  C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[8]  H. Goldschmidt,et al.  Preoperative elevation of serum C – reactive protein is predictive for prognosis in myeloma bone disease after surgery , 2006, British Journal of Cancer.

[9]  S. Zhang,et al.  Increased expression of angiogenin in gastric carcinoma in correlation with tumor angiogenesis and proliferation. , 2006, World journal of gastroenterology.

[10]  P. Tangkijvanich,et al.  Diagnostic role of serum interleukin-18 in gastric cancer patients. , 2006, World journal of gastroenterology.

[11]  J. Scheller,et al.  Interleukin‐6 Trans‐Signalling in Chronic Inflammation and Cancer , 2006, Scandinavian journal of immunology.

[12]  A. Trichopoulou,et al.  Plasma C-Reactive Protein and Risk of Cancer: A Prospective Study from Greece , 2006, Cancer Epidemiology Biomarkers & Prevention.

[13]  M. Gazouli,et al.  Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. , 2005, World journal of gastroenterology.

[14]  F. Chan,et al.  Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line , 2004, British Journal of Cancer.

[15]  N. Jing,et al.  Role of JAK/STAT Pathway in IL-6-Induced Activation of Vascular Smooth Muscle Cells , 2004, American Journal of Nephrology.

[16]  N. Ilhan,et al.  C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. , 2004, World journal of gastroenterology.

[17]  D. Harrison,et al.  The JAK/STAT signaling pathway , 2004, Journal of Cell Science.

[18]  T. Erlinger,et al.  C-reactive protein and the risk of incident colorectal cancer. , 2004, JAMA.

[19]  P. Heinrich,et al.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.

[20]  Yuan‐Chang Chung,et al.  Serum interleukin‐6 levels reflect the disease status of colorectal cancer , 2003, Journal of surgical oncology.

[21]  C. Herzog,et al.  Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. , 2003, JAMA.

[22]  Hsiu‐Po Wang,et al.  Correlation between serum levels of interleukin‐6 and vascular endothelial growth factor in gastric carcinoma , 2002, Journal of gastroenterology and hepatology.

[23]  Y. Ahn.  Cancer in Korea: present features. , 2002, Japanese journal of clinical oncology.

[24]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[25]  V. Praloran,et al.  Serum interleukin-8 (IL-8) and IL-6 concentrations in patients with hematologic malignancies. , 1996, Blood.

[26]  G. Neufeld,et al.  Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor (*) , 1996, The Journal of Biological Chemistry.

[27]  A. Gamian,et al.  Acute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancers , 2008, Clinical chemistry and laboratory medicine.

[28]  Tetsuo Sumi,et al.  Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor , 2005, Gastric Cancer.

[29]  H. K. Kim,et al.  Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. , 2003, European journal of cancer.